Enhanced External Counterpulsation (EECP): Historical Background in the Treatment of Coronary Artery Disease and Its Emerging Role in Chronic Heart

An epidemic of heart failure worldwide continues unabated. Recent developments in diagnostic and therapeutic techniques offer initial promise, but additional advances are needed to significantly alter this trend. Enhanced External Counterpulsation (EECP), which increases perfusion in the myocardium and other vascular beds, is known to decrease symptoms, increase functional capacity, and improve quality of life in patients with angina. Currently it is being investigated for the treatment of heart failure and, among potential new therapies, is unique in its noninvasive nature. This paper describes the current status of EECP for the treatment of heart failure and reviews its background in the treatment of coronary artery disease. (Türk Kardiyol Dern Arş 2004; 32: 309-317)